I dont think that there is any reason to be alarmed, I'm certainly not. The results of the Aussie trials are long overdue, but they seem reasonable and in line with FDA requirements. All the speculation out there is because they measured them in a different way, in fact way too much concern IMO. However we are getting to the business end of the fact finding, and its about results that will be accepted by FDA. Of course it would be better if we all knew the detailed hurdle but we dont. It seems it could have some subjectivity rather be a binary "it passed or not" type of test.
As for positive reaction, lots of people still here and holding proportionately large amounts. FIL still accumulating, they are circa 10% and buying at recent levels means they have spent close to $20m for their stake. I think my stake is big but thats one hell of a gamble, and they aren't selling down but buying up.
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp Provides Updated Australian Paediatric Study Results
Ann: ResApp Provides Updated Australian Paediatric Study Results, page-177
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 112 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)